NZ205569A - Production of clouding agent, stabilising agent, emulsifying agent, thickening agent or microbiological culture medium from dairy whey lactose permeate - Google Patents
Production of clouding agent, stabilising agent, emulsifying agent, thickening agent or microbiological culture medium from dairy whey lactose permeateInfo
- Publication number
- NZ205569A NZ205569A NZ205569A NZ20556983A NZ205569A NZ 205569 A NZ205569 A NZ 205569A NZ 205569 A NZ205569 A NZ 205569A NZ 20556983 A NZ20556983 A NZ 20556983A NZ 205569 A NZ205569 A NZ 205569A
- Authority
- NZ
- New Zealand
- Prior art keywords
- percent
- culture medium
- fraction
- microbiological culture
- weight
- Prior art date
Links
- 239000001963 growth medium Substances 0.000 title claims description 89
- 239000012466 permeate Substances 0.000 title claims description 62
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 title claims description 53
- 239000008101 lactose Substances 0.000 title claims description 53
- 238000009629 microbiological culture Methods 0.000 title claims description 25
- 235000013365 dairy product Nutrition 0.000 title claims description 19
- 239000003995 emulsifying agent Substances 0.000 title claims description 10
- 239000003795 chemical substances by application Substances 0.000 title claims description 5
- 239000003381 stabilizer Substances 0.000 title claims description 5
- 239000002562 thickening agent Substances 0.000 title claims 2
- 108010046377 Whey Proteins Proteins 0.000 title description 55
- 102000007544 Whey Proteins Human genes 0.000 title description 55
- 239000005862 Whey Substances 0.000 title description 52
- 238000004519 manufacturing process Methods 0.000 title description 15
- 238000000034 method Methods 0.000 claims description 66
- 239000007787 solid Substances 0.000 claims description 49
- 239000002609 medium Substances 0.000 claims description 41
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 38
- 230000008569 process Effects 0.000 claims description 36
- 230000012010 growth Effects 0.000 claims description 35
- 239000012138 yeast extract Substances 0.000 claims description 35
- 229940041514 candida albicans extract Drugs 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 239000008103 glucose Substances 0.000 claims description 32
- 244000005700 microbiome Species 0.000 claims description 32
- 239000000463 material Substances 0.000 claims description 30
- 239000000725 suspension Substances 0.000 claims description 29
- 235000015097 nutrients Nutrition 0.000 claims description 28
- 239000002253 acid Substances 0.000 claims description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 26
- 229910001868 water Inorganic materials 0.000 claims description 24
- 239000002244 precipitate Substances 0.000 claims description 23
- 239000007858 starting material Substances 0.000 claims description 21
- 238000000108 ultra-filtration Methods 0.000 claims description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 239000012528 membrane Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 18
- 230000001804 emulsifying effect Effects 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 15
- 235000013351 cheese Nutrition 0.000 claims description 12
- 239000000839 emulsion Substances 0.000 claims description 11
- 239000003208 petroleum Substances 0.000 claims description 11
- 231100000252 nontoxic Toxicity 0.000 claims description 10
- 230000003000 nontoxic effect Effects 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 9
- 239000003349 gelling agent Substances 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 238000000855 fermentation Methods 0.000 claims description 8
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 7
- 239000005018 casein Substances 0.000 claims description 7
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 7
- 235000021240 caseins Nutrition 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 7
- 229960002433 cysteine Drugs 0.000 claims description 7
- 239000000654 additive Substances 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 claims description 4
- 108010073771 Soybean Proteins Proteins 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 230000009965 odorless effect Effects 0.000 claims description 4
- 230000033116 oxidation-reduction process Effects 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229940001941 soy protein Drugs 0.000 claims description 4
- 230000009967 tasteless effect Effects 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 241000894007 species Species 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 108010076119 Caseins Proteins 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- 239000000551 dentifrice Substances 0.000 claims description 2
- 238000009792 diffusion process Methods 0.000 claims description 2
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 claims description 2
- 229940025294 hemin Drugs 0.000 claims description 2
- 230000002906 microbiologic effect Effects 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims 2
- 230000000717 retained effect Effects 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003283 colorimetric indicator Substances 0.000 claims 1
- 239000008157 edible vegetable oil Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 239000003531 protein hydrolysate Substances 0.000 claims 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 claims 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 50
- 229960001375 lactose Drugs 0.000 description 49
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 34
- 235000010633 broth Nutrition 0.000 description 30
- 239000007788 liquid Substances 0.000 description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 238000007792 addition Methods 0.000 description 24
- 239000000047 product Substances 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000000523 sample Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 229920001817 Agar Polymers 0.000 description 15
- 235000010419 agar Nutrition 0.000 description 15
- 239000007921 spray Substances 0.000 description 15
- 239000008272 agar Substances 0.000 description 14
- 238000009655 industrial fermentation Methods 0.000 description 14
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 13
- 235000011114 ammonium hydroxide Nutrition 0.000 description 13
- 239000008188 pellet Substances 0.000 description 13
- 239000012071 phase Substances 0.000 description 13
- 150000007513 acids Chemical class 0.000 description 11
- 239000006260 foam Substances 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000008121 dextrose Substances 0.000 description 6
- 239000008279 sol Substances 0.000 description 6
- 230000028070 sporulation Effects 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 230000001052 transient effect Effects 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000007667 floating Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000013081 microcrystal Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000008719 thickening Effects 0.000 description 5
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 108010005774 beta-Galactosidase Proteins 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- 229960003082 galactose Drugs 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- -1 nitrooen' Chemical compound 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 238000010979 pH adjustment Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 108010059881 Lactase Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000006172 buffering agent Substances 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 229920002492 poly(sulfone) Polymers 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 235000008983 soft cheese Nutrition 0.000 description 3
- 238000011146 sterile filtration Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 235000021119 whey protein Nutrition 0.000 description 3
- 101000782236 Bothrops leucurus Thrombin-like enzyme leucurobin Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000006457 gys medium Substances 0.000 description 2
- 235000011617 hard cheese Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000012465 retentate Substances 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- QYRPFJSPYKSYEK-VWURTLBMSA-N (2s)-2-amino-3-hydroxypropanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound OC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 QYRPFJSPYKSYEK-VWURTLBMSA-N 0.000 description 1
- PSLCKQYQNVNTQI-BHFSHLQUSA-N (2s)-2-aminobutanedioic acid;(2s)-2-aminopentanedioic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CCC(O)=O PSLCKQYQNVNTQI-BHFSHLQUSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000924691 Aristolochia bracteolata Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 241000197194 Bulla Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001573476 Filodes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 239000010014 Mentat Substances 0.000 description 1
- 101100434906 Mus musculus Angptl8 gene Proteins 0.000 description 1
- 229910017974 NH40H Inorganic materials 0.000 description 1
- 229920002274 Nalgene Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000010210 aluminium Nutrition 0.000 description 1
- 235000005550 amino acid supplement Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- IIIPKDOPFMZRHG-UHFFFAOYSA-N benzene ethyl acetate toluene Chemical compound C(C)(=O)OCC.C1(=CC=CC=C1)C.C1=CC=CC=C1 IIIPKDOPFMZRHG-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- PALQHNLJJQMCIQ-UHFFFAOYSA-N boron;manganese Chemical compound [Mn]#B PALQHNLJJQMCIQ-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- IYRDVAUFQZOLSB-UHFFFAOYSA-N copper iron Chemical compound [Fe].[Cu] IYRDVAUFQZOLSB-UHFFFAOYSA-N 0.000 description 1
- TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical compound [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000004993 emission spectroscopy Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 230000008303 genetic mechanism Effects 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000002135 phase contrast microscopy Methods 0.000 description 1
- MQMHJMFHCMWGNS-UHFFFAOYSA-N phosphanylidynemanganese Chemical compound [Mn]#P MQMHJMFHCMWGNS-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000002824 redox indicator Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 235000021572 root beer Nutrition 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- OJNFDOAQUXJWED-XCSFTKGKSA-N tatp Chemical compound NC(=S)C1=CC=C[N+]([C@H]2[C@@H]([C@@H](O)[C@H](COP([O-])(=O)O[P@@](O)(=O)OC[C@H]3[C@@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 OJNFDOAQUXJWED-XCSFTKGKSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229930195727 α-lactose Natural products 0.000 description 1
- 229930195724 β-lactose Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C13—SUGAR INDUSTRY
- C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
- C13K5/00—Lactose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Birds (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dairy Products (AREA)
Description
FORM 5.
S',Q#1
RejMU).
Fee: $80.00
NEW ZEALAND
205569
i
Insert number of Provisional Speci ficati on(s) (if anv) and datefs) of filing; otherwise leave blank.
PATENTS ACT 195 3
Number:
Da te:
iwwv <-an,M: 2.-5-83
&»eci!Ieatioo Filod:
Class: ll
RX5Cai|o<i R^SiijoO
,[!!!*!* !Q{F. f TKCcr? !!!!!!!!!!!!!
ft&Hcation Dots.:
P,Q, Mo; J.3Q&
COMPLETE SPECIFICATION
Insert Title • of Invention.
Insert full name, fulI street address and nationality of (each) applicant.
CONVERSION OF CLARIFIED DAIRY WHEY LACTOSE PERMEATES TO CULTURE MEDIA AND OTHER COMMERCIALLY USEFUL PRODUCTS
I/WE IGI BIOTECHNOLOGY INC., a Maryland corporation of
9110 Red Branch Road, Columbia, Maryland 21045, United
States of America hereby declare the invention for which I/we pray that a patenb may be granted to me/us and the method by which it is to be performed, to be particularly described in and by the follov/ing statement:-
fThe—f ollowing—page—i-s—numbacd—1 la -
Indicate if following page is numbered '1(a)'
2
205569
Tprhniral F i p 1 rl n-f thp Tnupntinn This invention relates to processes -for converting dairy whey -fractions into commercially use-ful products, to the novel products thus produced, and to methods of using them. More particularly, this invention relates to a process -for treating substantially deproteinized dairy whey lactose permeates <WLP) with a base to produce a lactose-rich aqueous solute -fraction which is capable o-f supporting good growth o-f a wide variety o-f microorganisms and a macrocrystalline cloud -fraction which can be converted to a dry, -free—f 1 owing, odorless and tasteless composition which has emulsi-fying and suspending properties which render it use-ful for a wide variety of applications in the food, pharmaceutical, cosmetics, and other industries.
205569
3
N.Z. PATENT OFF ICE
SEP 1984
RECEIVED
As noted by Alan 6. Lane in J. Appl. Chem. Biotechnol . 22: 165-16? (1977), the disposal o-f whey resulting -from the manufacture o-f cheese and casein presents environmental and economic problems o-f enormous magnitude, with the annual production of whey in the United States estimated to have a pollution strength equivalent to the sewage from 10 million people. While some whey is used as an animal feed <e.g. see U.S. Patents 3,343,962 and 3,497,359 to Herbert R. Peer and U.S. Patent 4,328,158 to Paul R. Austin et al.), most has been regarded as waste and disposed of by traditional methods. While recent developments in ultrafiltration <UF) technology have made it possible to recover proteins from whey economically, disposal of the_ remaining deproteinized whey lactose permeate presents serious difficulties since it contains most of the lactose (about 45 g/1) and thus most of the pollutional strength (biological and chemical oxygen demand) from the original whey.
In one approach to this problem, fermentation techniques have been developed for converting the lactose into food yeasts, e.g. K1 nyuprnmvrp<^ -fragility thereby attempting to overcome the limited market for lactose itself. Such processes have generally involved fermentation of the whey or the whey lactose permeate, first without prior concentration and later by dialysis culture techniques such as reported by Lane. While offering the potential for removing up to 98 percent of the lactose present in the whey lactose permeate, such methods suffer the disadvantage of yielding a single product of limited utility.
The dialysis continuous fermentation of deproteinized whey has been applied to the production of Lact.nhflr.i 1 lus cells, e.g. as reported by R.W. Steiber et al . in J. Dairy Sci. £3: 722-730 (1980). Using deproteinized whey as the substrate, the fermentor contents are maintained at a constant pH of 5.5 by the addition of ammonia and dialyzed through a semipermeable membrane against water; cell production was double that of ordinary continuous fermentation.
205569
Both sweet whey permeate and acid whey permeate have been used as a -feedstock in ethanol production using beta-gal ac tosi dase and fiarrharnmvrPQ rprpuig.iap, e.g. as reported by Barbel Hahn-Hagerdal in Applied Biochemistry and Biotechnology 2: 43-45 <1982). Although more than 58 percent of the lactose was converted to ethanol, the eluate contained less than 2 percent ethanol yield based on the weight/unit volume o-f whey permeate -feedstock.
The use o-f whole whey as a bacteriological culture medium has been reported by Emel Celikkol in Mikrobiyol. Bui. 2(4): 273-279 (1975) and in U.S.S.R. Patent 819,166. As summarized in Chem. Abs. 24: 72629u and 25: 59984n respectively, the -former process uses untreated whole whey, while the latter process removes lactose -from the initial whey and hydrolyzes the proteins therein. For reasons which have hereto-fore not been -fully appreciated by the prior art, neither o-f these methods has gained widespread use -for either industrial or clinical grades of culture media.
Uhey colloidal precipitates have found use as clouding, stabilizing, emulsifying, thickening, and gelling additives (depending in general on the concentration in which the precipitate is employed) to food grade compositions, e.g. as described by U.S. Patents 4,143,174 and 4,289,583 to Syed M.M. Shah et al. Shah et al. do not describe useful applications for the supernatant liquid which is separated from the colloidal precipitate.
A variety of solids can be obtained from dairy whey permeates, depending on the temperature, pH, and other conditions under which they are formed, e.g. see Eustache U.S. Patents 4,042,575 and 4,842,576. Pederson describes in Patent No. 4,202,909 a method for recovering lactose from whey permeates by forming a precipitate upon heating to 180-200°F, and separating the supernatant liquid therefrom. Other than the recovery of lactose, Pederson does not disclose any industrial or commercial uses for the precipitate or for the supernatant l iquid. U.S. Patent 4,036,999 to Donald A. -Grindstaff describes pretreatment of raw acid cheese whey by adjusting the pH to above 6.5 and separating insoluble solids therefrom. Separated solids
N.Z. PATENT OFFIC
SEP 1984
f- "" r;f; ] V"
are treated by adding calcium ion, heating and drying to -form a product which is useful as a non-fat dried milk substitute in bakery products. It has now been -found that a particular combination o-f temperature and pH employed in accordance with the present invention gives a unique combination of useful co-products, and that the solubility properties of the precipitate can be varied depending on the extent of water removed therefrom.
It is a general object of the present invention to provide a simple permeates into industrially useful products.
It is an overall object of the present invention to provide a method for converting deproteinized lactose rich dairy whey fractions into at least one fraction containing a microcrystal 1ine cloud material (i.e. formed of microscopic crystals not observable by the naked eye) and at least one lactose-rich aqueous solute fraction, each of which has further use in a variety of industrial, commercial and clinical applicat i ons.
It is a principal object of the present invention to provide a lactose rich product derived from lactose rich dairy whey fractions, which product is useful for formulating industrial fermentation media, clinical diagnostic culture media, and other growth media for culturing of microorganisms.
A further object of the present invention is to provide improvements in processes for culturing microorgani sms employing these media.
A second principal object of the present invention is to provide a mi crocrystal1ine cloud material useful as an emulsifying, suspending, and/or gelling agent.
Yet another object of the present invention is to provide improved methods for emulsifying and suspending a wide variety of compositions employing these agents.
and inexpensive method for converting deproteinized dairy whey
A more particular object o-f the present invention is to provide improved -food grade additives -for use in -foods, pharmaceutical carriers, cosmetic bases, dentifrice bases, and the like.
Upon study of the specification and appended claims, further objects, features and advantages of the present invention will become more fully apparent to those skilled in the art to which this invention pertains.
Bnie.f Dascr ip.t ion of the Drawings
Figures 1 and 2 are flew diagrams of a presently preferred process and practical applications according to the present invention.
Figures 3-5 are graphs shewing the effect of pH on the zeta potential of illustrative cloud fractions of the present invention determined according to the process of Example 15; those areas in which the zeta potential is at least about 5mV (either + or -) represent generally satisfactory pH ranges for the format i-on of stable emulsions or suspensions.
Figure 6 is a scanning electron micrograph <SEM) of a commercial preparation of spray dried industrial grade culture medium prepared according to the process of Example 10 of the present invention;
Figure 7 is an SEM of the microcrystal1ine cloud fraction obtained as a precipitate concurrently with the solute phase from which the culture medium shown in Figure 6 was produced;
Figure 8 is an SEM of a microcrystal1ine cloud fraction similarly obtained from a different source of deproteinized dairy whey lactose permeate; and
Figure 9 is ah SEM of a microcrystal1ine cloud fraction similarly obtained from yet another source of whey lactose permeate which contained a high protein level due to membrane leakage.
Bast MndP-fon-Camyi ng_Oul the Inupntinn
Brie-fly, the above and other objects, features and advantages the present invention are attained in one aspect thereof by providi a method for separating dissolved solids from deproteinized dairy whe.
205569
f
#
4
lactose permeate materials, which would otherwise -form a precipitate upon autoclaying the permeate, to form a) a lactose-rich aqueous solute phase, use-ful as a microbiological, culture medium, which does not -form a precipitate upon autoclaving; and b) a microcrystal1ine cloud precipitate which is useful as a food grade additive to cause clouding, stabilization, emu 1sification , and thickening of food, pharmaceutical, cosmetic, and other compositions.
The present invention is directed to a method for treating lactose rich deproteinized dairy whey fractions to form at least one product comprising microcrystal1ine cloud material and at least one fraction comprising a lactose rich aqueous solute phase. Each of these end products may be further processed according to the present invention to produce useful compositions or -to provide materials which are useful in industrial and commercial processes. In particular, the solute phase according to the present invention i$ useful as a microbiological culture medium for clinical and industrial uses, including aerobic and anaerobic fermentation processes. The microcrysta 11 ine cloud material formed according to the present invention can be utilized as an emulsifying and/or gelling agent, which can be particularly useful for emulsifying or gelling proteins useful as food additives, pharmaceutical compositions, cosmetics, and the like.
Generally, whole whey is presently commercial1y processed by ultrafiltration in order to collect the protein rich retentate. The lactose rich permeate from the ultrafiltration step has been further-treated to recover the lactose and/or lactic acid, or the permeate may be dried and used as a fertilizer. The present invention is directed to treatment of the lactose rich permeate to form other useful products.
Figure 1 shows a general process according to the present invention, wherein whole whey is subjected to ultrafiltration to produce a lactose rich dairy whey permeate . j^Xhe.-sol i ds concentr-atj on of the permeate is adjusted to an appropriate concenjJ^^^^fc^nd th|j pH which normally will be below 7 is adjusted to about ^V^IO. Th^x^jus'tment of the pH results in the
formation of a cloud which is separated from the supernatant by centrifugation and/or ultrafiltration. The solute fraction may be optionally spray dried for later use, or used as is for further processing as a microbiological culture medium. The cloud fraction may be used as is, concentrated to a paste or dried for use as an emulsifier, for emulsifying aqueous or oily liquids or in emulsifying or gelling proteins. The resultant emulsions or gej s may be combined with other ingredients appropriate for the desired end use.
Referring to Figure 2, the solute fraction may be supplemented with an appropriate nutrient, then sterilized by autoclaving or filtration. Alternatively, the unsterilized supplemented solute fraction may be optionally spray dried for storage until further use, then sterilized prior to use by autoclaving or filtration. The sterilized solute fraction, either unsupplemented or supplemented with additional nutrients, can then be utilized as a liquid or a solid culture medium. If a solid culture medium is desired, a gelling agent is added to form a solid culture medium and the medium is contacted with an appropriate microorganism, the microorganism allowed to grow and the microorganism and/or the desired biological product is isolated. If used as a liquid culture medium, the supplemented or unsupplemented solute fraction may be utilized in either batch or continuous processes. In a typical batch process the liquid solute fraction is contacted with the microorganism under suitable growth conditions, and transferred successively to larger tanks (staging). The desired microorganism or biological products -from the microorganism are isolated. Alternatively, the liquid solute fraction can be used in a continuous process wherein the microorganism is contacted with the medium and allowed to grow to a desired cell density. The nutrient containing medium is continuously flowed into the culture while simultaneously withdrawing spent nutrient. The spent nutrient is collected and the desired biological products removed therefrom.
Suitable deproteinized lactose whey permeates (WLP) which can be used as starting materials are commercial1y available or can be
prepared by techniques known to those skilled in the art -from either sweet or sour (acid) dairy whey derived from hard cheeses, e.g. Swiss or Mozarella, or from soft cheeses, e.g. cottage cheese. Commercially available starting materials which have been successfully employed herein include Foremost-McKesson, Inc. lactose permeate prepared according to the methods described in U.S. Patent 3,615,664 to Leo H. Francis (Figures 6, 8, and 9) and Express Food Company's deproteinized whey syrup solids (Figure 7).
The lactose rich dairy whey permeates suitable as starting materials according to the present invention are generally deproteinized, e.g. by ultrafiltration or other membrane separation techniques. The percentage solids content therein may vary, depending upon prior processing. The particular type of ultrafiltration equipment and membrane employed in preparing the WLP starting material does not appear to be critical, since comparable results have been obtained from WLP preparations filtered with commercial1y available Abcor (cellulosic and nonce 11ulosic tubular membranes), DDS (De Danske Sukkerfabrikker, polysulfone and cellulosic flat sheet membranes), Dorr-Oliver (polysulfone and cellulosic bonded plate membranes), and Ladish (polysulfone and cellulosic spiral wound membranes) ultrafiltration equipment. Since membranes generally have a molecular weight cutoff of about 17 - 20 kdal (ki1odaltons) for the primary permeate, it is important that the membranes employed do not have pinhole defects which result in protein leaks, as the quality of the final products is impaired with such materials. Conventional operating conditions for such ultrafiltration membranes are pH 0 - 14, temperatures of about 38 - 80°C, and pressures of about 60 - 145 psi.
The WLP starting material, either in spray dried form or obtained in a liquid stream at a concentration of 5-40 percent total solids (wt/vol), is either dissolved in or diluted with water or evaporated to a solids content of 2-28 percent, preferably about 18 percent solids. Concentrations much below this range may yield a liquid phase which has an inadequate nutrient content for use as a culture medium product (although acid WLP appears to have a higher content of
205569
N Z. PATENT OFFICE .
if
SEP 1984
- SCGIVlD
assimilable nitrogen sources than sweet WLP), while concentrations much above this range may -fail to stay in solution during processing. Excessively high concentrations above 28 - 25 percent solids also impede the removal o-f the WLP components which precipitate upon autoclaving.
These components, which are collectively referred to herein as a mi crocrystal 1 i ne cloud -fraction, are precipitated from the WLP solution by raising the pH thereof to precipitate the cloud material. This is generally accomplished by the addition of sufficient non-toxic Lewis base, preferably an inorganic base, e.g. an alkali metal hydroxide and especially ammonium hydroxide (which is preferably generated in siiu. by bubbling ammonia gas through the diluted WLP, forming the relatively nontoxic ammonium ion) to raise the pH of the diluted WLP to about 8-10, preferably to about pH 9. The material which is used to adjust the pH of the permeate does not appear to be critical provided that it is not, or does not form, materials which are toxic. The products according to the present invention may be utilized in food products, pharmaceuticals, cosmetics and as media for growing microorganisms; therefore the pH adjusting agent for such applications will be limited" to those materials which are nontoxic to animals and microorganisms. Upon adjustment of the pH as described above, a macrocrystalline cloud precipitate is formed. The temperature at which the precipitation step is carried out is not particularly critical. Conveniently, temperatures in the range of 28 - 58°C may be utilized.
This increase in the pH of diluted WLP results in precipitation of the microcrystal1ine cloud fraction, with optimal yield usually obtained at about pH 9. The optimum pH for removing all of the cloud fraction can be determined by autoclaving aliquots of the WLP solution after raising the pH thereof to selected values within the 8-10 range and separating the thus produced cloud fraction. If too low or too high a pH is employed, cloudy and/or dark colored solutions are obtained upon subsequent autoclaving the solute fraction.
11
205569
The precipitate is physically separated from the culture medium," e.g. by centrifugation at 1 1 ,7589 and ■filtration across a 0.4$jj pore size membrane or by ultrafiltration across a 10 - 100 kdal molecular weight exclusion membrane, generally 20 - 50. kdal and preferably 20-30 kdal, and saved for use as an emulsifying or suspending agent as discussed below. Centrifugation alohe without subsequent filtration is generally unsatisfactory, since the clear supernatant frequently turns cloudy upon subsequent autoclaving, thereby limiting its applicability as a culture'median. Ultrafiltration across a membrane of pore size less than 20 kdal, e.g. 10 kdal/ is unsatisfactory when the solute phase is the desired product since the resultant culture medium results in poor growth compared to one which has been filtered across a 20 kdal or larger pore size membrane. The cloud fraction may be dried and utilized as an emulsifying or gelling agent in various applications as described below.
The solute fraction may be sterilized in an autoclave or subjected to sterile filtration (preferably in the pH range of about 6.8 - 7.1) apd used as a culture medium for growth of microorganisms. The solute fraction contains useful quantities of assimilable carbon, nitrooen',
phosphorus and other nutrients, including the sugar sources lactose, sucrose, galactose. and glucose. Ihe. principal carbon source is the lactose present in the starting WLP. Of the available sugar in a 3.5 percent' (wt/vol) solids unsuppl onented media after autoclaving at 121°C/15 psi, a typical composition is: 53.0 percent by weight beta-lactose (11.8 mg/ml); -'44.8 percent by weight alpha-lactose + sucrose (9.97 ng/mL); 1.2 percent ty weight galactose (0.27 mg/ml); and 1.0 percent by weight glucose (0.23 mg/ml).
It has been found that WLP, although essentially proteir. free, generally contains adequate amounts of metabolizable nitrogen in the form of free ajnino acids and Iow molecular weight polypeptides. Thus, in accordance with the present invention, there is no need to hydrolyze separated proteins to increase the assi^Hable nitrogen content as described in U.S.S.R. Patent 817,166; ih'any event, most proteins have
205569
12
already been relieved during the ultrafiltration process and are not available as a component of the WLP starting material. If supplmentation of nitrogen sources is desired, it can be achieved fcy the addition of con/entional nitrogen sources, including yeast extracts and peptones of commonly available animal and vegetahle proteins, such as casein and soy. The source of nitrogen atoms then could be a yeast extract, yeast autolyzatef hydrolyzed casein, soy protein or soy protein lydrolyzate, or a mixture of these. Other sugar sources such as glucose, and buffering agents, cofactors, and the like, m^ be added as necessary to support growth of the microorganism of choice. Those of ordinary skill in the art cf microorganian culture can readily determine an/ necessary nutrient supplements, buffering agents (i.e., to an optimal pH range in which the organisn is viable), and the like which are necessary to grew a particular desired microorganism.
The solute fraction of the present invention is useful both in industrial scale processes and as a starting material for the preparation of various microbiological culture media which are useful in clinical diagnostic testing methods. For use with microorganisms which do not normally metabolize lactose, or for use in clinical screening applications where such organisms may be encountered, the metabolizable carbon content of the medium can be enhanced by the addition of glucose, generally to a total concentration of about 0.5 mg/ml.
The solute fraction may be utilized to prepare a solid or liquid clinical grade culture medium, a liquid or solid aerobic culture medium, a liquid or solid anaerobic culture medium, a general industrial fermentation medium, a fermentation medium for the production of antibiotics, a culture medium for the preparation of cheese, and the like.
An exemplary useful general purpose aerobic medium in accordance _wi.fch^ the present invention comprises an aqueous composition „ supplemented with yeast extract, amino acids and glucose in the xmto!lowing proportions:
clarified solute fraction at 3.5 percent solids (wt/vol) ^3OCT 19^7 f yeast extract <Amber 510) 0.05 percent by weight amino acid mix (U.S. Biochemicals) 0.5 percent by weight glucose (USP grade) 0.05 percent by weight above supplemented culture medium has a protein analysis (Cowry protein content) lower than conventional nutrient broths, as
205569
13
shown below in Table 1, there-fore it is unexpected that the supplemented medium according to the present invention would be use-ful ■for supporting the growth o-f microorganisms. A typical amino acid analysis is shown in Table 2. The data shown in Tables 1 - 4 are representative of the general purpose microbiological culture medium o-f Example 1 which has been supplemented with 0.5 percent by weight casamino acids, 0.05 percent by weight yeast extract, and 0.05 percent by weight glucose.
TABLE 1
Marii urn
8BL Nutrient Broth Di-fco Penassay Broth WLP Medium, supplemented Sk im Milk mg/ml Prntpin
4.8 3.3 1 .2 30.0
It may be seen -from the -following amino acid analysis of the above described supplemented solute fraction that it contains an adequate range of amino acids to support microorganism growth. However, should a particular application require an unusual amount of a particular amino acid, such as required for growi ng mi croorgan i srns which are deficient in the genetic mechanisms for producing a given amino acid, the medium can be supplemented accordingly.
14
205569
TABLE 2
1XB1EAI AMINO-
Amino .Ar i rl
Alan i ne Argi n i ne Aspartic acid Glutamic acid 61yc i ne Hi st i di ne I soleuc i ne Leuc i ne Lysi ne Me th i on i ne Phenylalan i ne Ser i ne Threon i ne Vali ne
3.8? 1 .05 2.63 9.45 1 .91 0.9 3 1 .83 3.38 3.0? 1 .03 1 .4 6 4.56 1 .90 3.45
The supplemented WLP medium exhibits good bu-f-fering capacity to both acid and base addition, as shown in Tables 3 and 4. This is an unexpected and advantageous property since most microorganisms will survive only within a limited pH range and the present supplemented solute -fraction exhibits buffering capacity comparable to that of conventional nutrient broths without the addition of buffering agents.
TABLE 3
pH after successive 8.1 ml additions of IN HC1 to 25 ml broth
Mprliiim
II
1
2
3
Difco Penassay Broth
6.92 6.64 6.34 5.96 5.28 4.37
ULP Medi urn, (supp1emen ted)
6.82 5.59 4.66 4.14 3.73 3.32
BBL Nutrient Broth 6.80 4.38 3.58 3.04 2.60 2.31
TABLE 4
BasE_BUE£EeifciG_c&Eani ~n pH after successive 0.1 ml additions of IN NaOH-to 25 ml broth
M p rl i 11 m
B
1
2
3 4
Di fco Penassay Broth
6.93 6.93 6.96 6.9? 7.02 7.05
ULP Medium
6.80 6.93 7.04 7.17 7.31 7.15
(supp1emented)
BBL Nutrient Broth 6.74 6.9? 7.19 7.37 7.55 7.71
The supplemented ULP medium can be prepared either in liquid -form or spray-dried, preferably to a moisture content of less than 10 percent by weight, e.g. about 6 percent by weight, for greater storage stability. Uhen preparing a liquid broth, any desired supp\ements can be added prior to autoclaving at 1210C for 15-20 minutes. In this manner, various types of culture media can be readily prepared from the basic unsupp1emented ULP solute fraction. Presently preferred media are :
1) a general purpose gncwth medium cf solute phase preferably supplonented with about 0.25 - 0.5 percent by weight casamino acids, 0.05 percent by weight yeast extract and 0.05 - 0.1 percent by weight glucose, which compares favorably with widely used general nutrient broths, e.g. Difco Penassay broth, Oxoid Lablemco broth and Nutrient Broth No. 2, and BBL Nutrient broth;
2) a primary isolation mediun (PIM) for the cultivation of both aerobic and araerobic microorganisms from primary clinical specimens. Ihis material is frequently supploriented with 0.25 - 0.5 percent by weight casamiro acids, 0.5 percent by weight yeast extract, 0.4 - 0.5 percent by weight glucose, 0.1 percent by weight agar or other gelling agent to reduce oxygen diffusion and 0.05 percent by weight cysteine HCl as a reducing agent. When boiled before use to reduce the oxygen content, the resulting clinical grade medium ccmpares favorably with widely used thiogly col late broth; and
3) a pre-reduced, sterile, anaerohically prepared mediun for the cultivation of facultative and obligate anaerobic microorganians, which is preferably supplemented with 0.25 - 0.5 percent by weight casamino acids, 1 percent by weight yeast extract, 0.5 percent by weight glucose, and 0.001 percent by weight resazurin as an oxidation-reduction indicator. The latter medium is boiled under a nitrogen atmosphere for approximately 10 minutes and then supplemented with 0.2 percent by weight cysteine HCl, 0.50 mg/ml hemin, 1 mg/ml vitamin K^, and adjusted to pH 7.8 with ammonium hydroxide prior to being stored under a nitrogen atmosphere • To prepare tubes of pre-reduced agar medium, agar is ■first added to the tubes to give the final concentration desired, and pre-reduced broth medium added to the agar in the tubes. After autoclaving at 121°C/15 psi for 20 minutes, the remaining solid agar was dissolved by inverting the tubes several times. This medium has an oxidation-reduction potential o-f -150mV or lower, and the col orimetrie redox indicator turns pink upon oxidation of the medium; and
4) an industrial fermentation mediun, in either liquid or solid form, e.g. containing solute fraction diluted to 3.5 percent (wt/vol) solids and supplemented with about 0.25 percent by weight Mber 510 brewer1 s yeast extract. For the solid medium, ary conventional gelling agent can be added, e.g. about 1.5 percent by weight agar. A typical analysis of such an industrial fermentation medium is as follcws:
205569
17
I. Analysis:
(mg/100 om)
Protein, Kjeldahl
(percent N by weight 12.10 x 6.32)
Protein, Lowry 3.5
percent by weight fat <1.0
percent by weight ash <1.9
percent by weight carbohy- 81.5
drate percent by weight moisture <4.5
Bulk density, gm/cc 0.63
Solubi1i ty i n H2O,
gms/100 ml 30°C 24.5
Sugan_Eco£il£ (percent):
Galac tose 0.8
Glucose 0,7
Lac tose 31.5 Sucrose trace
Bl B2
Ni ac i n
0.38 16.60
21.70
Xcacp Miaprals: <mg/100 gm)
Alumi num Bar i um Boron Cal c i urn Ch r om i um Copper Iron
Magnesi um Manganese Phosphorus Sodi um Stront i um Z i nc
Mi r.rrib.i ni ogical: CFU
Col i -form
<0 .906 8.121 0.242 26. 21 <0.121 <0.131 0.181 34.97 " 0 .060 341.56 580.14 0.785 0 .604
220/gm negat i ve
AmiHQ_6cid_Ecafil£:(mg/109 g)
Argi ni ne Cyst i ne G1u t am i c acid G1yc i ne Hi st i di ne I soleuc i ne Leuc i ne Lys i ne Me th i on i ne Phenylalan i ne Thr eon i ne Tryp tophan Tyros i ne Vali ne
160 30 330 230 100 198 270 270 90 130 150 40 170 130
85 percent passes Tyler 270 screen pH a-ffprr autflclau ing: 6.5 (3 percent total solids)
/«
18
205569
The above described industrial -fermentation formulation supports growth with the following industrially important organisms:
£_t££ plfjfTl YT P Qf- i c P 11 c
E£niclllium_no±a±um
Saccharcrayces cerevisiae Aspangillus-iiigac.
produces strep totTiyc i n (detectable levels within 24 hrs.) and pronase produces penicillin (detectable levels wi thin 24 hrs.)
produces ethanol produces citric acid
) Industrial fermentation media with increased glucose content. One such mediun consists1 of solute fraction diluted to 2.0 percent sciLids (wt/vol), and suppLonented with 0.25 percent by wei^it ftnber 510 yeast extract and 1.0 percent ky weight dextrose. Another sudi medium consists of salute fraction that is .-passed through an iirmobil ized lactose reactor, diluted to 3.0 percent (wt/vol) solids, and suppioriented with 0.25 percent by weight ftnber 510 yeast extract. The residence time of the solute fraction in the reactor is used in oorrjunction with the pH and temperature of ttie reaction to control, the firal dextrose concentration of this mediun.
It may be seen there-fore that the solute -fraction may be utilized, either in the supplemented or unsupp1emented form, to produce antibiotics, such as streptc-myc i n and penicillin. Furthermore, the solute fraction according to the present invention may be used as a star tip culture growth medium, such as in the biological production o-f Olfc^rd aind soft cheeses.
While relatively unimportant for use in certain industrial Proce5ses» the optical clarity of a broth culture medium highly important in clinical applications. For this purpose, it is
£N
E f advisable to screen samples of supplements intended to be used, as i n some^i||stances it has been found that certain samples will not yield .j red clear product. At high yeast extract concentrations of around 1 percent by weight, Amber ex 510 water soluble autolyzed yeast extract obtained fran Arriber Laboratories, Inc., and Nestle yeast extracts obtained from the BBL Microbiology Division of Becton, Dickinson and
Co. have proved satisfactory. Amino acid supplements from Difco
Laboratories, Inc., U.S. Biochemical Corp., and Marcor Development Corp. are likewise satisfactory -for use in the present process.
For use as a liquid culture media, the solute -fraction obtained by the process of this invention can be sterilized by conventional methods such as sterile filtration or autoclaving. Once autoclaved, the sterile media should not be re-autoclaved, as this causes a material reduction in microbial growth potential. If sterile filtration alone is employed, generally through a 0.22 jul filter, it is necessary to reduce the pH of the broth to about 6.8 - 7.1 by the addition of a suitable nontoxic acid such as HCl. This can be accomplished either before or after- filtration, but in any event must be done prior to use. Sterilization of liquid culture media by autoclaving has been found to inherently reduce the pH thereof from about pH ? to the desired range, and for that reason an initial pH adjustment to pH 9 together with autoclaving is presently preferred. The reason for this is not fully known, but may be the result of polypeptides or other organic buffering constituents of the medium being degraded by the heat of autoclaving.
In addition to its use as a broth, the basic unsuppIemented solute phase of the present invention can be made up into solid or semisolid plates or slant tubes by the addition of a gelling agent such as agar agar, Carr^ageenan, pectin, silicone gel, guar gum, locust bean gum, various gellable polysaccharides, etc. according to known techniques. These gelling agents can be used with or without other additives such as defibrinated sheep or horse blood, proteins, litmus, etc. to form culture media suitable for use as blood agar, protease assay agar, litmus agar, etc. For example, the liquid medium is easily prepared in the form of pour plates by the addition of 1.5 percent (wt/vol) agar. In general, the unsupp1emented solute phase culture medium of the present invention can be modified as desired by the addition of a wide variety of supplements depending on its ultimate intended use, e.g. see the Media section at pages 681-656 of the American Type Culture Collection Catalogue of Strains I, 15th Edition (1932).
205569
Alternatively, the solute -fraction can be spray dried to a powder in order to increase shelf life and save transportation costs. Because the solute fraction must be in a concentrated form for spray drying,
the use cf WLP starting materials in concentrations greater than the 3.5 percent (wt/vol) generally onpLcyed for liquid media is preferred, and concentrations as high as 20 percent (wt/vol) have proven satisfactory. As the sclids content of the WLP starting material approaches 30 percent (wt/vol), it has been found that sane of the solid material may ranain in suspension and not be precipitated fcy pH adjustment. Spr^ drying of media containing supplorients such as 0.05 percent ky weight yeast extract and/or 0.25 - 0.5 percent ty weight casanino acids is readily accomplished. Spray drying of . unsupplemented solute fraction generally requires drier air to compensate for the lack of seed particles in the supplements, which dry rapidly and form a nucleus upon which the rest of the materials can dry. Use of a portable, general-purpose spray; drier such as that manufactured by Niro Atomizer, Inc. is quite satisfactory with a temperature of about 2000C and an outlet stack temperature of about 80°C. Using such conditions, the moisture content in the basic supplemented medium is reduced to about 6 percent by weight. will be appreciated that the culture media of the present
N v e n t jjpn can be employed in the fermentative production of i b i o't i c s, enzymes, organic acids, alcohols, and ketones and can also t
b^jijsed as a starter culture growth medium, e.g. in the biological l30CT1987rijuction of hard and soft cheeses such as American, Swiss, Italian, ieddar, Mozarella, and cottage cheeses. These UILP media are distinctly different from whole whey-based cheese starter cultures as illustrated, in±£n_alia, by G.W. Reinbold et al. U.S. Patent 3,993,700; D~.L"r^ndersen et al . U.S. Patent 4,020,185; R.S. Porubcan et al . U.S. Patent 4,115,199; andU.E. Sandine et al. U.S. Patent 4,232,255.
The microcrystal1ine cloud fraction which is precipitated at an alkaline pH, preferably at about pH 9, and separated from the culture medium by centrifugation or ultrafiltration across a 20 - 100 kdal membrane is generally harvested as an aqueous pellet material which
205569
21
has the consistency o-f shortening at 4°C and becomes more -free—f 1 owi ng upon warming to room temperature. When dried, this precipitate is a tasteless, odorless, chalky white -free-flowing powder; typically, about 15 percent by weight of the input WLP solids which are processed are recovered W as this dried precipitate pcwder.
This precipitate is different in nature from whey permeate precipitates reported by other investigators. Unlike the superficially similar materials reported by Shah et al . in U.S. Patents 4,1*43,174 and 4,209,503, the microcrystal1ine cloud fraction of the present invention is insoluble in petroleum ether, as shown in Table 5. The physical characteristics of the microcrystal1ine cloud fraction of this invention are critically dependant upon the form in which the precipitate is recovered. When recovered as a concentrated liquid, it forms a gel in water and is immiscible in petroleum ether. When further concentrated into a paste form, the microcrystalline cloud fraction becomes insoluble in both water and petroleum ether. Once dried, e.g. to about 6 percent by weight moisture, the microcrystalline cloud fraction is only transiently suspendable in water but is still insoluble in petroleum ether.
TABLE 5
SBLlJBlU.IX_D£_£LDlJI>_£fiA£Iim
Sflluaoi
.Sol i,ihi 1 i ty
Coneentrafprl r.lnurl Prartinn Ppllpf;
Ethyl acetate
Benzene
Toluene
Chi or of or m
Petroleum ether
Methanol
Ethanol
Propanol
Bu tanol
IN HCl
IN NaOH
insoluble, nondispersing paste insoluble, nondispersing paste insoluble, nondispersing paste insoluble, nondispersing paste insoluble, nondispersing paste very cloudy suspension very cloudy suspension very cloudy suspension sii gh t suspens i on cloudy suspension cloudy suspension
/juLwaf
205569
22
Dry CLoud Fraction,
Water, 5 percent solids (wt/vciL) Water, 10 percent solids (wt/vol) Water, 20 percent solids (wt/vol)
slight suspension sLight suspension slight suspension
Petroleum ether, 5 percent solids (wt/vol) insoluhle particles PetraLeun ether, 10 percent solids (wt/vol) insolubLe particles Petroleum ether, 20 percent solids (wt/vol) insoLuhLe particles
When chemically analyzed by ICP analysis, the microcrystal1ine cloud fraction o-f this invention is also demonstrably different in nature from both unprocessed -spray dried UILP and the precipitate that forms when spray-dried ULP is resuspended to 20 percent concentration (wt/vol) and cooled at 4CC for 72 hours, as shown in Table 6. The data shown are from the same starting material sample, which had a maximum water solubility at room temperature of about 20 percent, a normal pH at that concentration of 5.5 to 6.0, and contained less than 1 mg/100 g. of carbohydrates and essentially no protein or fat. Data were obtained by ICR analysis according to Industrially Coupled P1 asina-A t om i c Emission Spectroscopy Method 3.005 of the American Organization of Analytical Chemists and compared to a sample prepared according to the process of Pederson, U.S. Patent 4,202,90? which involves heating to only 140° to 150°F. All samples were prepared by resuspending 20 percent (wt/vol) spray-dried ULP in water prior to individual processing.
205569
23
TABLE 6
Spray Dcipri U1LE Calcium 348.-438
Iron 8.11-.12
Phosphorous 488.-491 Magnesium 150.
Zinc Copper Sod i um C-hromi um Alum i num Bar i um Stront i um Boron Manganese
6.06-.08 0.025 774.-863 0.036-.037 1.1-1.3 0.025-.028 0 .11-.22 0.06-.07 0.005-.011
Alkaline pH Ecex i p i tatp
,392.
6.65
782.8
,733.
0.7?
0.75
461 .6
0.48
52.96
0 .82
1 .54 3.70 0 .21
Cold Pederson
Precipitate Precipitate 4°R, 7? hr^ 222£~ '
,800.
6.5? 11,448. 2,378. 3.42 0.7? 718.
7,934.
4.77 4,075. 548.2 1 .39 0.37 600 .9
1 .57
0.50
.66
6.50
0.57
0.57
6.60
3.74
0 .631
0.38
0 .21
0.18
a -function o-f pH
By determining the zeta potential as microcrystal1ine cloud -fractions prepared -from various sources of starting materials in accordance with the present invention, suitable pH ranges can be determined in which stable emulsions or colloids can be -formed. Since the zero-poi nt-o-f-charge corresponds to the pH in which the materials in suspension are least stable (not unlike the isoelectric point or pi for proteins), pH values which give a zeta potential o-f at least about 5mV are generally preferred, with greater deviation -from the zero-point-o-f-charge generally resultin the greatest stability. However, in the acid range, such high acid
N.Z. PATENT OFFICE
- ■
SEP 1984
IGCEWED
!
may result in degradation o-f polypeptide components present in the microcrystal1ine cloud fraction.
Taking into account these unique solubility properties, an air dried microcrystal1ine cloud fraction of the present invention can be employed in a wide variety of industrial applications, e.g. as a food grade emulsifier or suspending agent for pharmaceutical, cosmetic, and food materials using techniques known in the art.
Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The following preferred specific embodiments are, therefore, to be construed as merely illustrative and not limitative of the remainder of the disclosure in any way whatsoever. In the following Examples, the temperatures are set forth uncorrected in degrees Celsius; unless otherwise indicated, all parts and percentages are by weight.
EXAMPLE 1
7 g of WLP (obtained from Express Foods Co. and similar to products commercial1y available from Foremost McKesson, Inc. and other sources) was made up to 200 ml. with deionized water <3.5 percent solids content, wt/vol). The mixture was stirred for a few minutes to mix well, as some solids tend to fall out of solution if the mixture is not stirred. The pH was increased from an initial pH of 6.99 to 8.99 by the addition of 2.15 ml of 5.5 N NH4OH while stirring, and centrifuged for 10 minutes at 8500 rpm <ll,300g) in a Sorval1 RC-5B centrifuge using a GS^i rotor refrigerated at 4°C. 1.26 g of a soft, white microcrystal1ine cloud fraction pellet were obtained per 100 ml of starting solution. The supernatant was poured through a 0.45u, 115 ml Nalgene fi1tration unit, yielding 200 ml of clear material having, a pH of 9.84. After autoclaving at 121°C/15 psi for 28 minutes, a dull orange and crystal clear unsupplemented culture medium was obtained, having a final pH of 7.87.
I N.Z. PATEN l v.'
r 10 SEP 1984
y rec^T"
As a control, the above process was repeated using whole whey as the starting material. The initial pH was 6.26, and 2.4 ml o-f NH4OH were added to bring the pH up to 3.98. Following centr i -fugat i on , 1.08 go-fa hard, tan pellet were obtained per 188 ml o-f starting material. The supernate was not clear, but had -fluffy material floating throughout it. Only about 25 ml of the supernate could be passed through the filter unit until it clogged and the filter had to be changed. Following filtration, the supernate was still cloudy and had a pH of 8.98. After autoclaving, a dull orange, cloudy liquid was obtained having a pH of 7.88.
EXAMPLE 2
Following the procedure of Example 1, a microbiological culture medium was prepared from acid whey having an initial pH of 4.45 which was obtained from cottage cheese production at the Giant Food, Inc. dairy plant at Lanham, Maryland. The whole acid whey was ultrafi1tered thru a 38 kdal Dorr-Oliver filter unit, yielding a primary retentate and a primary permeate. The primary permeate was adjusted to pH 9 with NH4OH and the ultrafiltration process was repeated, yielding a secondary microcrystal1ine cloud fraction and a secondary permeate. The secondary permeate was supplemented with 8.25 percent casamino acids, 8.05 percent yeast extract, and 8.85 percent glucose prior to autoclaving for 28 minutes at 121°C/15 psi. The resulting autoclaved culture medium was clear and golden in color, with a pH of 8.15.
EXAMPLE 3 Enaciftllalxon-uitli. Qthar Rasfcs The procedure of Example 1 was followed, except KOH was used to adjust the pH. From an initial pH of 6.89, 8.2 ml of 6N KOH and 8.2 ml of IN KOH were added to bring the pH to 3.92. 1.66 g of cloud fraction were obtained as a soft, white pellet per 188 ml of starting material. Following filtration, the supernate was clear and had a pH
9 p, c r r 6
0 j J u 7
205569
1QSCFV}84
o-f 8.78. After autoclaving, the liquid was golden colored and very slightly cloudy, with a -final pH o-f 6.25
When NaOH was substituted -for the NH^OH in the procedure o-f Example 1, the initial pH of 6.88 was rai sed to pH 8.98 by the addi t i on of 8.45 ml of 3N NaOH. Centrifugation yielded 1.62 g per 188 ml of starting material of microcrystalline cloud fraction as a soft white pellet. After ultrafiltration across a 8.45u membrane, the supernate was clear and had a pH of 8.75. After autoclaving, a golden colored, siight1y c1oudy liquid was obtained having a final pH of 6.25.
The autoclaved clear culture media from Examples 1 and 3 were evaluated for their ability to support the growth of common laboratory culture strains, EarllXus subilJLLs 6851a, Entjernhar tpr aprngenp-s
E13843, and Fdrhpr i rhi a mli HS. Tubes of culture media, both unsuppl emented and supplemented with 1 percent BBL yeast extract,-- 8.5 percent Difco casamino acids, and 8.5 percent sucrose (Sigma Chemical Co.), were inoculated and incubated at 35°C for 5 hrs, after which optical density readings were made at 668 nm. Difco Penassay broth and BBL Nutrient broth were used as controls. The results in this and the following experiments were scored according to the following scale, which roughly correlates to half-log differences in measured optical density:
EXAMPLE 4
+
+ + +
+ + + +
+ +
Excellent growth; O.D. 8.3-1.0 Good growth; O.D. 0.1-8.3 Moderate growth; O.D. 8.83-8.1 Some growth; O.D. 8.885-8.83 No growth; O.D. 8-0.885.
The results are shown in Table 7.
N.z. patent OFFICE
SEP 1984
205569
r.iil tnpp Mprlinm
TABLE 7
Re£ 1 iminary fir\Dui±b-££C££ain^ R. c.juht.i..l-Ls
£^—rnl i
Difco Penassay broth
+ + + +
+ + + +
+++ +
BBL Nutrient broth
+ + + +
+ + + +
+ + + +
3.5 percent WLP* (NaOH)
+ +
+ + +
+ + +
3.5 percent WLP* (NaOH) + supp
+ + + +
+ + + +
+ + + +
3.5 percent WLP* (KOH)
+ +
+ + +
+ + +
3.5 percent WLP* (KOH) + supp
+ + + +
+ + + +
+.+ + +
3.5 percent WLP* (NH4OH)
+ + +
+ + +
+ + +
3.5 percent WLP* (NH4QHHSUPP
+ + + +
+ + + +
+ 4 + +
* as. WLP sol i ds
EXAMPLE 5
In order to evaluate the importance o-f the pH employed -for precipitation o-f the mi crocrystal 1 i ne cloud -fraction, a series of culture media supplemented as in Example 2 were prepared in which the initial pH was adjusted to between 4 and 11 using HCl or NH4OH as required. With the exception of the initial pH, the media were prepared as in Example 1 and the supplement added prior to autoclaving, at which time all of the samples appeared similar and filtered easily. The differences in the products obtained following autoclaving are shewn in Table 8.
28
205569
TABLE 8
4 with HCl clear, 1ight green
4.5
with HCl clear, light green
.5
6 no addi t i on sii gh 11 y opaque
6/9
7 wi th NH40H
very cloudy, light ye 1 lew
6.1
8 with NH4OH
very cloudy, golden
6.4
9 wi th NH4OH
clear, root beer color
7.1
19 with NH4OH
very dark brown
3.8
11 with NH4OH
like 1i qu i d chocolate
9.7
EXAMPLE 6
Following the procedure o-f Example 4, whey permeate culture medium produced according to the procedure o-f Example 1 and supplemented with 8.25 percent casamino acids and 0.95 percent yeast extract, both with and without 8.95 percent glucose, was compared with Di-fco Penassay broth and BBL nutrient broth -for its ability to support the growth o-f a representative variety o-f cl i n i cal 1 y important microorganisms. The results are presented in Table 9 and show that the solute phase culture media o-f this invention compare -favorably with two current widely accepted industry standards.
2?
205569
TABLE 9
REPRESENTATIVE GROWTHS IN LIQUID MEDIA
m
Whey Permeate Whey Permeate DIFCO BBL Media <suppl.) Media <suppl.) Penassay Nutrient ui/nu.t piiim^e ut/plxirq<*p Bcnlh Rrnth
aubi i 1 La riflfila + + + +
not done
>+ + + +
+ + + +
Eschanich ia cnl i-Uft
+ + + +
not done
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
not done
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
Prntpua
+ + + +
+ + + +
+ + + +
+ + + +
Klflisialla
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
♦
Salmonella tvph imilP i um I T9 + + + + fih i qp11 a annnpL + + + +
+ + + +
+ + + +
++ + +
+ + + +
+ + + +
+ + + +
Salmonella.
+ + +
+ + + +
+ + + +
+ + +
205569
re
1 10 SEP 1984
EXAMPLE 7 Fffprt of AutnrlauiriQ nn firnuiih In order to evaluate the importance o-f achieving a neutral pH in the final product through the autoclaving process, a filter sterilized glucose supplemented medium control was prepared otherwise corresponding to the culture medium used in Example 6 except that the final pH was adjusted to pH 7 by the addition of HCl rather than as a result of the autoclaving treatment. The results are shewn in Table 10.
205569
31
TABLE 18
REPRESENTATIVE GROWTHS IN LIQUID MEDIA
Autoclaved Filter Sterilized DIFCO
BBL
M i rrnnpgan i gjn
Bar i11 us suhJti lis rifl'Fil a
Esrhpr i rh.i.a
Fntprnhar tpp
BcqIeus
Whey Permeate Whey Permeate Mprlia (snpp)
+ + + +
+ + + +
+ + + +
■fapral i s, F19433 + + + + Staphylococcus
+ + +
+ + ++
K1 phyi p 1 la pne.umnn i ap...23352 + + + +
+ + + +
+ + + +
+ + ♦ +
+ + + +
+ + +
+ + + +
+ + + +
+ + + + + + + +
Penassay Nutrient Brnth Rrnth—
+ + + +
+ + + +
+ + + +
+ + + +
+ + +
+ + + +
+ + + +
+ + + + + + + +
+ + + +
+ + + +
+ + + +
+ + +
+ + +
+ + + +
+ + + +
+ + + + + + + +
sonnpi
Salmnnp1 la typhimnrinm ?la
+ + + +
+ + + +
+ + +
+ + + +
+ + + +
+ + +
It can be seen -from the last entry on the above table that there are apparently some nutrients required -for the growth o-f £almnnpl 1 a typh imur i nm which are changed by the autoclaving treatment and become not as readily metabolizable as in the sterile filtered medium. Nonetheless, both the autoclaved and sterile -filtered media were superior to the nutrient broth control.
205569
Following the procedure of L.V. Holdeman et al . (Ed.) in Anaerobe Laboratory Manual, 4th Edition (1977), a pre-reduced anaerobic culture medium was prepared by weighing out the dry ingredients 8.5 percent casamino acids, 1 percent yeast extract, and 8.5 percent dextrose immediately before use, adding water and resazurin, and heating under a nitrogen atmosphere. The solution was gently boiled until the resazurin turned from blue to pink to colorless in 5-18 minutes. After cooling in an ice bath under a nitrogen atmosphere, the cysteine was added. This was done after partial reduction of the medium by boiling in order to prevent oxidation of the cysteine, since oxidized cysteine can be toxic for some fastidious anaerobes. The pH was adjusted to 7.8 with NH4OH as measured by test paper while bubbling nitrogen through the liquid, which was then dispensed into tubes which had been flushed wi th nitrogen. To prepare tubes of pre-reduced agar medium, agar was first added to the tubes to give the final concentration desired, and pre-reduced broth medium added to the agar in t?e tubes. After autoclaving at 121°C/15 psi for 20 minutes, the remaining solid agar was dissolved by inverting the tubes several times.
EXAMPLE 9
Liquid anaerobic culture media were tested against three strains of Rartprnidps for its ability to support anaerobe growth. Test samples containing 8.85 percent yeast extract plus 0.85 percent glucose (Medium 1), and 1.8 percent yeast extract plus 8.5 percent glucose (Medium 2, from Example 8) were inoculated with the anaerobic microorganisms. Difco brain heart infusion broth (BHI) was used as one control medium; a medium containing 1 percent tryptone, 2 percent yeast extract, and 2 percent glucose (TYG) served as a second
9
05569
33
N.Z. PATENT OFFICE
SEP 1984
control. Optical density readings were made during the first eight hours of incubation. The results are summarized in the following Table:
TABLE 11 ANAEROBIC GRCWTH SCREENING
-£H1_£e_o±£i_ _IYil-B£c±li_
Bar tpr i nrlps
Bac ter i nrlps icagilis
Bar t PxiodES ic.agi 1 i s .47?=!
+ + + +
+ + + +
+ + + +
+ + + +
+ + +
+ + +
+ + + +
+ + + +
+ + + +
Mprtiiim ?
+ + + +
+ + + +
+ + + +
EXAMPLE 10 Prpparatinn nf Basic Cul tnr£-H££LLum—£o£
3.5 percent WLP (wt./vol; commercially available from Foremost-McKesson, Inc. or Express Foods Co.) was adjusted to pH 9 with NH4OH and u1trafi1tered through a 38 kdal Dorr-Oliver filter unit. The permeate was supplemented with 8.25 percent Amber BYF100 yeast extract prior to autoclaving for 28 minutes at 121°C/15 psi . The resulting autoclaved culture medium was only slightly cloudy, golden in color, and had a pH of 6.71. If a clear medium is desired, a yeast extract that is readily soluble, such as Amberex 510 yeast extract may be substituted for Amber BYF180.
EXAMPLE 11 Industrial Fermentation Prnrp^s Rar ilitis—c£t£us—suhs... th.»c.iiigl£asls^—uar.Bedinet obtai ned from Dr. Howard T. Dulmage of the U.S., Department of Agriculture Cotton Research Institute, Brownsville, Texas was selected to exemplify the
34
205569
capability o-f the culture medium o-f the present invention to support an industrial -fermentation process using the methodology described by Dulmage et al. in J. Invert. Pathol. 22: 273 - 277 <1973). This organism produces a de1ta-endotoxin and is used as a biological insecticide in the control o-f 1 ep i dopter-an pests, e.g. as the worm killer available under the trademark DIPEL 4L -from Abbott Laboratories, Chicago, 111. The development o-f parasporal crystals and spores o-f Ra riling thnr i ngi pn^j g. was monitored under phase contrast microscopy following the procedure o-f L. A. Bulla et al . described in Appl i ed M i cr-obi ol ogy IB <4>: 498 - 495 (1969).
Heat shocking at 78°C was used to compare the degree o-f sporulation in the modified culture medium of Example 16 containing 0.25 percent Amber BYF188 compared with the GYS medium described by Bulla et al . and the B4, B4b, and B8b media described by Dulmage et al. Heat resistance was used as a measure of completed spore formation.
After 24 hr, sporulation approached its maximum level with the culture medium of this invention, whereas sporulation with the GYS medium did not approach maximum levels until 48 hr; in addition, the maximum sporulation level obtained was 108 fold higher than with GYS.
Similar experiments comparing the culture medium of this invention with B4, B4b, and B8b media showed sporulation after 24 hours from 18 to 100 fold higher with the former; in addition, the maximum sporulation level obtained was from 5 to 18 fold higher.
The basic culture medium of Example 1 was supplemented with 0.25
were recorded and are shown in Table 12. This experiment demonstrates that the culture medium of this invention can be used in industrial fermentation processes.
EXAMPLE 12
percent Amber BFY 188 yeast extract before autoclaving. Aliquots of the resulting medium were inoculated with several organisms of industrial interest. Colony morphologies and dry cell weight yields
205569
N 7- PATENT OFFiCE_
SEP 1984
TABLE 12 COLONY GROWTH CHARACTERISTICS
Strain tt-noiaturn
Sirpptnmxce.s .gnisaus Sac.char0tnyr-es.cpcg.ui si ae
Cn 10By Mnr phnlngy single, large hyphal mat disperse, beadlike growth wel1 di spersed well dispersed
Dry r p 1 1 hip i gh t y i p 1 rift
0.76g/100 ml
0.47g/108 ml
0,21g/180 ml 0.237g/108 ml
* 5 days after 1/10 vol. inoculation and incubation at 30°C wi th shak i ng.
EXAMPLE 13
An t i h i nt i r Prnrlnrtinn
The same basic culture medium, unsupplemented, was used to demonstrate the production of antibiotics by two commonly used industrial microorganisms. The results, which are reported in Table 13, demonstrate that, while not yet optimized, drug production did occur in useful quantities.
TABLE 13 ANTIBIOTICS PRODUCTION
Sltaia penicillin streptomyc i n
0 .0864 Un i ts/ml 0.80735 Units/ml.
* One day after 1/18 volume inoculation and incubation at 25-38°Cwith agitation
205569
t: z. PATENT OFF ICE
36
1CSEP1984
EXAMPLE 14
Solute fraction prepared as in Example 1 was supplemented with 8.5 percent casamino acids, 8.05 percent yeast extract, and 0.85 percent glucose. Tubes o-f broth were inoculated with various microorganisms and growth was observed either by plate count as reported in Table 14 or visually as reported in Table 15.
TABLE 14
PLATE COUNT OBSERVATIONS OF GROWTH
f:nl nnv r.nnntc. ppr- ml. a-ftpr ?4 hr^ at 3?0f:
Organism Tpsifcd
Supplemented Solute
Control Media < 8HI, PABA, AGAR)
N. me.QiagiiidJ-5.
Ln.f I upn7ft£
R. nu i t i s
88 68 1258
250 8
1388
205569
37
N.Z. PATENT OFFiC£
105EP1984
RECEIVED
TABLE 15 VISUAL OBSERVATIONS OF GROWTH
Alraligpnp^ -fapralig.
Bacillus, c e.c.aus
B*_subillis
B_ thyc-ingiansls
Cilnoharter -frpnnrlii
P. plnngata
Rhnrln^p i r i H nm riihrnm Ralmnnplla typhimnrinm SEttalii-manctsctas S i a p h y .1 ococcus_ami£.us Strpptnrnrrns -fapralis
BiiQulh-Ltfiibi n 4R hrs at 3fl°C Arinptnhartpr ralrnarpti mjs Mi rrnrnrrng. c.p _
Fungi grew after 2-3 days
Aspergillus ninsr Q-oratiaii^cas-stemnn i t is
Ppn i r i 1 1 i um =.p .
EXAMPLE 15
The stability o-f colloids comprising three mi crocrystal 1 i ne cloud ■fraction samples was measured by determining the zeta potential. Each sample was diluted in deionized water to a 8.180 percent suspension, and the electrophoretic mobility was determined using a Zeta-Meter (Zeta-Meter, New York, NY). With this instrument, a suspension o-f the sample is decanted into an electrophoretic cell and a potential applied across a pair o-f electrodes inserted into the cell. The average time for a particle to move hor i zon tall y between two lines o-f a grid is observed thru a microscope and recorded. This time is then translated into the zeta potential using standard conversion charts.
The -first sample suspension, air dried Express Foods mi crocrystal 1 i ne cloud -fraction, was onl y moderatel y stable, with the solid dispersing slowly over a period o-f 15 minutes and some larger particles settling quickly to the bottom o-f the container- when
205569
stirring was stopped. The second sample suspension, Express Foods mi crocrystal 1 i ne cloud -fraction wet pellet, was extremely stable, while the third sample, FGA-1 mi crocrystal 1 i ne cloud -fraction, also appeared extremely stable but was stirred -for 24hr prior to measurement o-f its zeta potent i al.
The effect of pH on the zeta potential was determined for each of the three materials. The zeta potential for each sample was negative in the neutral pH range, and became more negative with increasing basicity, and positive with increasing acidity. There was some evidence for dissolution in the acid pH range. The zero-point-of-charge, i.e. the pH at which the zeta potential of the surface of the particle reached zero, was as follows: Sample 1 = 4.2; Sample 2 = 2.4; Sample 3 = 4.5. The results of plotting pH vs. zeta potential are shown in Figures 3-5.
EXAMPLE 16
Part i r 1 p fii7P D t c.tr i hn t i nn
Four samples were examined and photographed by scanning electron microscopy <SEM) to determine particle size. The scanning electron micrographs are shewn in Figure 6 through 9; the distance between solid white squares on the lower border of each photograph is 100um. Figure 6 represents the basic culture medium for industrial fermentations prepared as described in Example 10. Figure 7 represents microcrystal1ine cloud fraction from whey lactose permeate (Express Foods Co.) generated as described in Example 1, separated from the culture medium by ultrafiltration, and subsequently spray-dried. Figure 8 represents microcrystal1ine cloud fraction produced from whey lactose permeate (Foremost-McKesson, Inc.) generated by Mozarella cheese manufacture. The microcrystal1ine cloud fraction was generated as described in Example 1, separated from the culture medium by ultrafiltration, and subsequently spray-dried. Figure 9 represents microcrystal1ine c':jd fraction produced from whey lactose permeate (Foremost-McKesson, Inc.) generated by Swiss cheese
205569
39
manufacture. The mi crocrystal 1 i ne cloud -fraction was again generated as described in Example 1, separated -from the culture medium by ultra-filtration and subsequently spray-dried.
EXAMPLE 17
The solubility characteristics o-f the microcrystal 1 i ne cloud fractions of Example 16 (Figures 7 - 9) in water, petroleum ether, IN HCl, and IN NaOH were examined. 8.5 g, 1.8 g, and 2.0 g of cloud material were added to 18 ml aliquots of each solvent. The solutions, were shaken vigorously and allowed to stand. The resulting solubility profiles appear in Table 16.
TABLE 16
SOLUBILITY CHARACTERISTICS IN WATER,
P-nmpnnnrt
Water, 5 percent soli ds
Spray
Transi ent suspensi on, i nsol ubl e
Spray
Dr i pd FfiA-i
Cloudy,
part i al suspensi on
Water,10 percent solids
Water, 20 percent soli ds
Pe troleum ether , 5 percent soli ds
Petroleum ether, 10 percent soli ds
Petroleum ether, 20 percent soli ds
Transi ent suspensi on, i nsoluble
Transi ent suspensi on, insoluble
Insoluble <fi 1m)
Insoluble (•film)
I nsol ubl e (film)
Cloudy,
part i al suspens i on
Cloudy,
p ar t i a 1 suspensi on
Insoluble (f ilm)
Insoluble (•film)
Insolubl e (film)
Cloudy,
part i al suspensi on
Cloudy, partial suspensi on (si gn i f i cant amount of stable foam)
Spray
Dc.i.ed FGA-?
Cloudy,
„par t i al suspensi on
Cl oudy,
part i al suspens ion
Cl oudy,
part i al suspensi on
Insoluble (film)
Insoluble (film)
Insoluble (film)
Cloudy, almost complete, suspens i on
Cloudy, partial suspensi on (floating mater i al)
IN HCl, 5 percent soli ds
IN HCl, 20 percent soli ds
Transient suspensi on, i nsoluble
Cloudy, partial susp.
SEP 1984
TABLE 16 ( CONTINUED) SOLUBILITY CHARACTERISTICS IN WATER,
Cnmpniinrl
IN NaOH, 5 percent soli ds
Spray
Dr i prt PP.
Part i al1y soluble, supernate c1 ear ye 11ow
Spray
Driprl FfiA-1
Part ially sol ubl e, supernate clear orange (f1 oat i ng mater i al)
Spray
Driprl FfiA-?
Par t i al 1 y soluble, supernate c 1 ear ye 11ow (■floating mater i al)
IN NaOH, 20 percent soli ds
Part ially soluble, supernate clear orange
Stable, dark orange -foam
Partially soluble, clear orange supernate (si gn i -f i cant amount o-f floating mater i al)
205569
12
K.i
SEP 1984
RECEIVro
EXAMPLE 18
The s-olubilities o-f the microcrystal 1 ine cloud -fraction materials o-f Example 18 (Figures 7-9) were characterized -further in a variety o-f organic solvents. In general, 0.5 g o-f cloud material was added to 5ml of each solvent. The solutions were shaken vigorously and allowed to stand. In the case of glycerol, 5g were added to 50ml and the solution was stirred mechanical1y. The resulting solubility profiles appear in Table 17.
TABLE 17
SOLUBILITY CHARACTERISTICS IN ORGANIC LIQUIDS Srnlubi 1 ,i ty. nf r.lniirl Frartinns at 1ft pprrpnt uit/.unl^
Di el ectr- i c
Spray
Spray
Spray
Constant
Dried
Dr i ed
Dr- i ed
Rnlupnt rf ?5or:
F.F.
FPto-1
FfiA-9
G1 ycerol
42.5
2
2
2
1
Methanol
32.6
7
7
7
7
Ethanol
24.3
4
7
7
7
Acetone
.7
7
3
3
2
2-Propanol
.1
7
2
7
8
n-Butanol
17.1
7
7
7
7
Ethyl
acetate
6.0
1
Chloroform
4.8 (20°C)
9
Ethyl ether
4.3
9
Toluene
2.4
7
6
9
Benzene
2.3
7
6
6
9
Hexanes,
prac t i cal
1.9 (20OO
7
7
7
9
1 = Cloudy, total suspension
2 = Cloudy, partial suspension
3 = Cloudy, partial suspension with floating material
4 = Cloudy, slight suspension
= Partial, particulate suspension
6= Partial, particulate suspension with f1 oating material
7 = Transient suspension, insoluble
8 = Transient partial suspension, insoluble
9 = Insol ubl e
205569
r43- —
| 10sepi984
\
L—
[7 received
EXAMPLE 1?
A solution o-f mi crocrystal 1 i ne cloud -fractions -from Example 16 (Figures 7 and . 8) was prepared by shaking 20 parts o-f the moist precipitate in 188 parts o-f water. Thirty parts of 5 percent vinegar were added to this solution and the resultant mixture was stirred, thickening noticeably. Fifty parts of sucrose were then added with stirring, causing further thickening. Thereafter, 188 parts of liquid vegetable oil (peanut oil) were added arid the mixture was homogenized in a Waring blender at high speed for 2 minutes. The resultant emulsion layer was stable for at least 4 hours and had the viscosity of a mayonnaise mixture.
As a control, the above process was repeated without the addition of microcrystal1ine cloud fraction. This process showed no thickening of the mixture following the addition of vinegar and sucrose. The oil and water layers formed no emulsion, and separation into two distinct layers was complete only two minutes after attempted homogenization.
EXAMPLE 28 Fmnl si f i rat i-on-of-DranQP Pnlp-Uastt Following the procedure of the preceding example, 18 ml of orange pulp wash (the HjO soluble fraction of citrus pulp and ruptured juice vesicles) was added to 18 ml of distilled water containing 2g of microcrystal1ine cloud fraction of Example 16. Immediately after mixing, all of the material was in a single emulsion layer and remained so for at least two hours. Approximately 18 hours later, a sma;l 1 portion of liquid had formed a lower, clearing layer under the emulsion. With the microcrystal1ine cloud fraction sample of Figure 8, the emulsion layer had solidified.
As a control, the above process was repeated without the addition of microcrystalline cloud fraction. The lower, clearing layer began to form after less than 38 minutes, and the remaining emulsion layer was not thick as in the samples containing the cloud fraction.
205569
EXAMPLE 21 Fmii Isifinalion nf Hexanes
This example i11ustrates the ability o-f the mi crocrystal 1 i ne cloud ■fraction o-f this invention "to emulsify non-polar hydrocarbons. Following the procedure of the preceding Examples, 18 ml of technical hexanes was added to 18 ml of distilled water containing 2 g of microcrystal1ine cloud fraction from the two different sources. Immediately after- mixing, an upper foam layer extended to the top of the test tube, and the foam was still at this height after 37 minutes. Approximately 18.5 hrs. later, the foams in both tubes had become gelatinous.
As a control, the above process was repeated without the addition of microcrystal1 ine cloud fraction. The technical hexanes and water separated completely into two different, clear phases immediately after vortex mixing was ended.
EXAMPLE 22
Using South Dakota intermediate grade crude oil containing 1.6 percent sulfur, 18 ml of the oil sample were added to 18 ml distilled water containing 2 g of both of the microcrystal1ine cloud fraction of the preceding examples. Samples containing microcrystal1ine cloud fraction formed two stable phases. The upper phase became gelatinous, with the Figure 8 microcrystal!ine cloud fraction sample gelling at about 98 minutes, and the Figure 7 sample gelling less dramatical1y after about 18 hours. The Figure 8 sample exhibited a relatively poor capacity to coat a plastic tube compared to the Figure 7 and control samples.
As a control, the above process was repeated without the addition of microcrystal1 ine cloud fraction. The oil and water formed a single liquid phase and formed no gel upon standing.
205569
EXAMPLE 23
Fmii 1 q. i f i r a t i nn nf Rpntnnitp
This example illustrates the use of the microcrystal]ine cloud ■fraction to emulsify particulate inorganic solids. Following the procedures of the preceding examples, 0,2g bentonite was added to 28 ml distilled water containing 2g of dry microcrystal1ine cloud fraction obtained according to Example 16, With the Figure 3 microcrystal1ine cloud fraction, an upper foam and a lower, frothy layer were formed. The frothy layer was stable for at least 18 hours.
As a control, the above process was repeated without the addition of microcrystal1ine cloud fraction. Immediately after mixing, a single, frothy layer was obtained which, within approximately 8.5 hr, also shewed the presence of a lower, clear layer.
EXAMPLE 24
This example illustrates the capacity of microcrystal1ine cloud fraction to emulsify and gel protein. 188 ml aqueous solutions were prepared using microcrystal1ine cloud fraction generated from ULP commerci&11y available from Express Foods Co. and Savorpro 75 whey protein concentrate which is also commercial1y available from Express Foods Co. Samples were whipped in a Waring blender at high speed for 3 mi nutes. Foam height and the viscosity of the resulting emulsi ons were documented, demonstrating that the addition of either 18 or 28 percent microcrystal1ine cloud fraction increased both the foam height and viscosity of 18 percent whey protein concentrate solutions. The results are shown in Table 18.
TABLE 18
EMULSIFICATION OF PROTEIN BY CLOUD FRACTION
109 ml aqueous- solution whipped at high speed ■for 3. mi nutes
Foam height when 109ml 1i q settled out in 200ml beaker
Viscosity (Seconds for 5ml to drop from pi pet; relative to a value of 3 for H^O
.10 percent WLP
percent WLP, 10 percent cloud fract i on
percent WLP, 20 percent cloud fract i on
1 .8 cm
2.5 cm
3.5 cm
4 sec
sec
.S sec .
EXAMPLE 25 CbIUqq nl...Pc.ote ia_by nioujd-Enaclion In addition to emulsifying protein, microcrystal1ine cloud fraction also gels protein at concentrations lower than that at which gelling would normally occur. Using the same materials described above, 18 ml aqueous solutions were prepared, vortexed, and incubated at 80°C for 20 minutes. With the addition of 20 percent microcrystal1ine cloud fraction, 10 percent whey protein concentrate solidifies at 30°C. Without the addition of microcrystal1ine cloud fraction no solidification of the 18 percent protein solution occurs, as shown in Table 1?:
205569
4?
, '..TBJT OFFICE j
10sep1984
L-
i
Aqueous Rnlntinn
TABLE 19 GELLING OF PROTEIN SOLUTIONS £M£ -f nr ?fl . m i nuias
percent cloud -fraction 20 percent cloud fraction
percent WLP 20 percent WLP
percent cloud fraction +
percent WLP 10 percent cloud fraction + 20 percent WLP
percent cloud fraction +
percent WLP 20 percent cloud fraction + 20 percent WLP
slight suspension w/large pellet sediment si ight suspension w/large pellet sediment cloudy suspension, thick coating sol id pellet milky suspension w/pellet sol id pellet
1:1 solid pellet and thick coating solid pellet
EXAMPLE 26 Preparation of Industrial Fermentation
Permeate is prepared as in Example 16, with the exception that 20 percent (wt./vol.) whey lactose permeate is used as the starting material. The resulting permeate is spray-dried and used to prepare basic culture media for industrial fermentations that are increased in glucose content relative to that of Example 10. One such culture medium is produced by preparing a 2.0 percent solids solution of spray-dried permeate and supp1ementing with 0.25 percent Amber 510 yeast extract and 1.0 percent dextrose prior to autoclaving for 20 minutes at 121°C/15 psi. The resulting autoclaved culture mediurn is clear, golden in color, and has a pH of 6.5. Another such culture medium is produced by first preparing a 15 percent solids solution of spray-dried permeate, the solution having a pH of 6.5.
This solution is passed through an immobilized enzyme reactor of the type described by A. G. Hausser et al. in Rintprhnnlngy.and Bi.flfth.Yii.es—XXL! pages 525-539 (1983) at a rate of 6 ml/mi n at a temperature of 37°C, resulting in the conversion of 47 percent of the
2055
permeate lactose to glucose and galactose by immobilized acid lactase enzyme. The enzymatic conversion was carried out without pH
adjustment o-f the permeate and was, there-fore, at a pH that was non-optimal -for the acid lactase enzyme. This use o-f a non-optimal pH resulted in a 47 percent conversion, which was desirable for this example since it resulted in an approximately 1 percent glucose concentration when the permeate solids were adjusted to 3 percent. The resulting medium was then comparable to the 1 percent glucose-supplemented medium. Adjusted to a solids level o-f 3,0 percent, this lactase treated permeate contains 1.24 percent glucose. 3.0 percent 1actase-treated permeate, supplemented with 0.25 percent Amber 510 yeast extract and autoclaved -for 20 minutes at 121°C/15 psi , gives a clear, golden culture medium with a -final pH o-f 6.5.
The glucose supplemented and 1 ac tase-treated basic culture media o-f this example were tested against several microorganisms for their growth support characteristics relative to the basic industrial culture medium described in Example 10. The results appear in Table 20 below.
Medi um
TABLE 20
REPRESENTATIVE GROWTH IN INDUSTRIAL FERMENTATION MEDIA WITH INCREASED GLUCOSE CONTENT
Microorganism
S..aureus S^.f aeralis B. c.uht i 1 is
P.flunr&scens
Basic culture medium for industrial fer-mentat i on.
+ +
+ + + +
+ + + +
+ + + +
+ + + +
Glucose supplemented basic culture medium ■for industrial "fermentation. + +
+ + + +
+ + + +
+ + + +
+ + + +
Lactose-treated basic culture medi um for industrial fermentation. + + +
+ + + +
+ + + +
+ + + +
+ 4 + +
205569
p.—_—-—-—i atent office i
SEP 1984
RECEIVED I
Industrial culture media with a wide range o-f glucose to lactose ratios can be prepared by varying the extent o-f either the dextrose supplementation, or the lactose hydrolysis described above. Specifically, if a high level of lactose hydrolysis is desired a neutral lactose enzyme is immobilized using a neutral buffer system and no further pH adjustment is made before permeate is passed through the reactor. Further, media with differing glucose to lactose ratios can also be prepared by dry blending the appropriate amounts of permeate solids with dextrose, or permeate solids with lactose-treated permeate soli ds.
EXAMPLE 27
Following the procedure of Example 2 but adjusting the primary permeate to pH 8.5-9.0 and supplementing the secondary permeate with 0.25 percent Amber 518 or Amber 1803 yeast extract gives an essentially neutral clear golden culture medium which is suitable for growing commercial cheese starter cultures available from Chris Hansen Laboratories, Milwaukee, Wisconsin and for growing cultures of St r.e p±ncQf c u S-.r.nemncis (ATCC 19257) , Sirep±£>corcus_Lacl-Ls (ATCC 19435),
Culture growth on these media, as measured by viable plate count, equals growth produced by currently available cheese starter culture media when temperatures and agitation are controlled identically and no external pH control is used. If, however, pH is controlled by the addition of a base to maintain the culture broth in the range of pH 6.0 to 6.5, the cell density reaches 5 to 10 times that obtained in the currently available commercial media. Furthermore, these growth levels can be obtained reproducably in 8 hrs with, appropriate inoculum as opposed to 16-20 hrs typically required in commercial media such as Nordica, In-Sure and Phase 4, which include internal phosphate buffering.
205569
N.Z. PATENT OFFICE
I 1V/~M-'
1
CT
10SEP1984
The preceding examples can be repeated with similar success by substituting the generically or specifically described reactants and/or operating conditions o-f this invention -for those specifically used in to which this invention pertains can easily ascertain the essential characteristics thereof and, without departing from the spirit and scope of the present invention, can make various changes and modifications to adapt it- to various usages and conditions.
As can be seen from the present specification and examples, the present invention is industrially useful in providing a plurality of commercially useful products from lactose rich dairy whey permeate which has heretofore normally been considered a waste material. One principal product comprises microbiological culture media which are capable of supporting good growth of a wide variety of microorganisms; a second product comprises a food grade emulsifying or stabilizing agent which is capable of emulsifying or stabilizing a wide variety of produc ts.
the examples. From the foregoing description, one skilled in the art
51
205569
Claims (1)
- WHAT WE CLAIM IS: 1: A process for converting dairy whe/ lactose permeate into a microcrystalline cloud fraction and a solute phase, which ccmprises: a) raising the pH c£ a substantially deproteinized dairy whe/ lactose permeate, having a pH below 7, to a pH between 8 and 10 to form a lactose-rich aqueous solute phase and a microcrystalline cloud fraction, which fraction contains substantially all of the dissolved solids f rem said permeate which would form a precipitate upon autoclaving said permeate for 10-20 minutes at 121°C and 15 psi, so that a clear, light colored solute having a pH of substantially 7 can be formed when the alkaline permeate is so autoclaved, said microcrystalline cloud fraction being characterised by being insoluble in petroleum ether after drying to form a pewder; b) separating the microcrystalline cloud fraction -from the solute phase; and c) recovering at least one o-f the microcrystalline cloud -fraction and the solute phase. 2: A process according to claim 1, wherein the pH is raised to substantially pH 9. 3: A process according to claim microcrystalline cloud -fraction is separated -from the ultra-filtration across a 10 - 100 kdal membrane -filter. 4: A process according to claim 1, -further comprising lowering the pH of the separated solute phase to 6.8-7.1. 5: A process according to claim 4, wherein the pH is lowered by the addition c-f a nontoxic acid to the solute phase. 6: A process according to claim 4, wherein the pH is'Tower-ed-by autoclaving the solute phase to form a sterile micro culture med i um. 1, where i n the solute phase by 205569 52 7: A process according to claim 6, wherein the pH is lowered without the addition o-f extraneous acid to the solute phase. 8: A process according to claim 1, -further comprising spray drying the separated solute phase to a moisture content o-f less than 18 percent by we i gh t. 9: A microbiological culture medium capable of supporting the growth of microorganisms under suitable growth conditions, consisting essentially of the solute phase obtained according to the process of claim 1, which is substantially free of components which would be retained by a filter having a pore size which passes components having a molecular .we i gh-t below 100 kdal and which contains substantially all of the components which would be passed by a filter having a pore size which would retain components having a molecular weight above 20 kdal. 10: A microbiological culture medium according to claim 9^ which is substantially free of components which would be retained by a filter having a pore size which passes components having a molecular weight below 30 kdal. 11: A microbiological culture medium according to claim 9 having a pH of 6.8 - 7.1. 12: A microbiological culture medium according to claim 9 in| a sol ids content of substantially 3.5 percent (wt/vol) . nil Ict 1987 yy I 13: A sterile microbiological culture medium according to 14: A microbiological culture medium according to claim 9 in the form of a free-f1owing powder having a moisture content of less than 10 percent by weight. 53 205569 15; A microbiological culture medium according to claim 9, •further comprising a growth promoting amount of extraneous nontoxic assimilable carbon atoms. 16: A microbiological culture medium according to claim 15, wherein the source of carbon a tans is glucose. 17: A microbiological culture medium according to claim 9, further comprising a growth promoting amount of extraneous nontoxic assimilable nitrogen atoms. 13: A microbiological culture medium according to claim 17, wherein the source of nitrogen., atoms is a yeast extract, yeast autolysate, hydrolyzed casein, soy protein or soy protein hydrolyzate, or a mixture thereof. 19: A microbiological culture medium according to claim 9, further comprising an effective amount of a nontoxic gelling agent. 20: A microbiological culture medium according to claim 9, having nutrient grcwth characteristics of a fermentation medium, characterized fcy having a solids content of substantially 3.5 percent (wt/vol), and further comprising substantially 0.25 percent fcy weight water - soluble ^bre^er1 s yeast extract. 1. v 21: A microbiological culture mediun according to claim 9, having nutrient grcwth characteristics comparable to penassay broth or nutrient °\»hroth, and further comprising 0.25 - 0.5 percent by weight hydrdyzed 'casein, substantially 0.05 percent fcy weight yeast extract, and a total glucose content cf 0.05 - 0.1 percent fcy weight. : A microbiological culture mediun according to claim 9, having nutrient growth characteristics comparable to thiogly col late broth, and further comprising an effective amount cf a nontoxic gelling 54 20S56cI agent to reduce oxygen diffusion therein, 0.25 - 0.5 percent fcy weight hydrolyzed casein, substantially 0.5 peroent fcy weight yeast extract, substantially 0.05 percent fcy weight cysteine HCl, and a total glucose content of substantially 0.5 percent fcy weight. 23: A microbiological culture medium according to claim 9, adapted for the cultivation of anaerobic bacteria, further canprising substantially 0.25 percent fcy weight hydrolyzed casein, substantially 1 percent fcy weight yeast extract, substantially 0.2 percent by weight cysteine HCl, substantially 0.05 peroent (wt/vol) hemin, substantially 0.1 percent (wt/vol) vitamin , a total glucose content of substantially 0.5 percent fcy weight, a pH of substantially 7.8, an oxidation-reduction potential of -150 mV or less,and an effective amount of an oxidation-reduction colorimetric indicator. 24: A microbiological culture medium according to claim 23, wherein said indicator is substantially 0.001 percent fcy weight resazurin. 25: In a bulk microbiological starter mixture comprising viable microorganisns and a suitable nutrient mediun therefor, the improvement wherein said nutrient medium is the microbiological culture medium according to claim 9. 26: An improvement according to claim 25, wherein said microorganisms are cheese-producing microorganisms. 27: In a process for growing a microorganian in vitro under submerged culture nutrient growth conditions in a culture medium containing assimilable carbon, nitrogen, and phosphorus sources, the imprcvenent wherein said culture mediun is the culture medium of claim 9. 28: An improvement according to claim 27, wherein the microorganisn is a bacterium. 205569 55 2?: An improvement according to claim 27, wherein the microorganism is selected -from the group consisting o-f Bar i 1.1 jus, Lactobacillus, KluxuEComxcas, and Sacchac.nmyces species. 39: An improvement according to claim 27, wherein the rn i C r oor g an i sm is RariUtic mrpm c.nhc . thur i ngi pnc,i C,, 31: An improvement according to claim 27, wherein the mi croorgan i sm is selected -from the group consisting o-f As.p.£.cQi 11ns, EenicilJLLum, and Slxsptraaycas species. 32: An improvement according to claim 31, wherein the microorganism is PpniriIlium nntatum- . 33. An improvement according to claim 31, wherein the mi croorgan i sm i s Strpp trimyr£S-Qr.Ls£xis. 34: An improvement according to claim 27, wherein the mi croorgan i sm is obtained -from a clinical isolate. 35: A process according to claim 1, -further comprising drying the separated microcrystalline cloud -fraction to -form a tasteless, odorless, chalky white free—flowing powder. 36: A nontoxic food grade additive consisting essentially of the tasteless, odorless, chalky white free-f1owing powder obtained according to the process of claim 35. 37: In a food, pharmaceutical, cosmetic, or dentifrice composition of matter comprising an effective amount of an added clouding agent, stabilizing agent, emulsifying agent, or thickening agent, the improvement wherein the agent according to claim 36. * 1 o * 205569 56 r* - \^y> 38: In a process for -forming a stable emulsion or suspension o-f a plurality of immiscible materials by adding an emulsifying or stabilizing agent thereto, the improvement wherein said emulsifying or stabilizing agent is the additive of claim 36. 39: An improvement acoording to claim 38, wherein said immiscible materials include an oil and water as the major portion thereof. 40: An improvement according to claim 39, wherein the oil is an edible vegetable oil. 41. A process as claimed in claim 1 substantially as herein described with reference to the accompanying drawings and to the examples herein. 42. A microbiological culture medium as claimed in claim 9 substantially as herein described with reference to the accompanying drawings and to the examples herein. J. D. HARDIE & CO. Patent Attorneys for the Applicant(s).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/418,067 US4544637A (en) | 1982-09-14 | 1982-09-14 | Culture media from clarified diary whey lactose permeates |
US47157083A | 1983-03-02 | 1983-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ205569A true NZ205569A (en) | 1988-03-30 |
Family
ID=27023962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ205569A NZ205569A (en) | 1982-09-14 | 1983-09-13 | Production of clouding agent, stabilising agent, emulsifying agent, thickening agent or microbiological culture medium from dairy whey lactose permeate |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0119254A4 (en) |
AU (1) | AU569047B2 (en) |
CA (1) | CA1202812A (en) |
DE (1) | DE3390215T1 (en) |
DK (1) | DK238584A (en) |
ES (1) | ES525573A0 (en) |
GB (1) | GB2138664A (en) |
IL (1) | IL69699A0 (en) |
IT (1) | IT1170217B (en) |
NZ (1) | NZ205569A (en) |
WO (1) | WO1984001104A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4698303A (en) * | 1985-02-15 | 1987-10-06 | Engenics, Inc. | Production of lactic acid by continuous fermentation using an inexpensive raw material and a simplified method of lactic acid purification |
NZ216353A (en) * | 1985-06-05 | 1988-05-30 | Univ Kentucky Res Found | Manufacture of lac + fungi |
US4771001A (en) * | 1986-03-27 | 1988-09-13 | Neurex Corp. | Production of lactic acid by continuous fermentation using an inexpensive raw material and a simplified method of lactic acid purification |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2123203A (en) * | 1936-01-29 | 1938-07-12 | Kraft Phenix Cheese Corp | Protein mineral complex and process for making same |
FR1443098A (en) * | 1965-01-20 | 1966-06-24 | Improvements in cheese making | |
US3930039A (en) * | 1971-07-30 | 1975-12-30 | Molkerei J A Meggle Milchindus | Method of preparing a protein concentrate from whey |
CH556143A (en) * | 1972-09-11 | 1974-11-29 | Nestle Sa | PROCESS FOR PREPARING A SOLUBLE FRACTION OF SMALL MILK PROTEINS. |
FR2274231A1 (en) * | 1974-06-13 | 1976-01-09 | Baignes Ste Radegonde Laiterie | Purifying and upgrading milk by-prods - using sterilising ultrafilters followed by fermentation |
US4036999A (en) * | 1974-08-30 | 1977-07-19 | Stauffer Chemical Company | Treatment of whey |
FR2288473A1 (en) * | 1974-10-22 | 1976-05-21 | Manche Union Coop Agr Laiti | PROCESS FOR TREATMENT OF CHEESE WHEY, IN PARTICULAR WITH A VIEW OF THE EXTRACTION OF GLYCOPROTEIDES AND SIALIC ACID |
FR2288477A1 (en) * | 1974-10-22 | 1976-05-21 | Manche Union Coop Agr Laiti | PROCESS FOR THE PRODUCTION OF SIALIC ACID AND GLYCOPROTEINS FROM CHEESE WHEY |
US3963580A (en) * | 1975-02-10 | 1976-06-15 | Microlife Technics, Inc. | Method for determining the suitability of milk for bacterial fermentation activity |
US4143174A (en) * | 1975-07-24 | 1979-03-06 | Beatrice Foods Co. | Food composition containing whey colloidal precipitate |
DE2631655A1 (en) * | 1976-07-14 | 1978-01-19 | Franz Xaver Julius Prof Roiner | Culture concentrate for acid foods - prepd. by controlling whey or permeate acidification to reduce pH and increase self stopping |
US4202909A (en) * | 1976-11-22 | 1980-05-13 | Patent Technology, Inc. | Treatment of whey |
AU521879B2 (en) * | 1978-05-18 | 1982-05-06 | Beatrice Foods Co | Whey precipitate food modifier |
US4402986A (en) * | 1981-07-23 | 1983-09-06 | Stauffer Chemical Company | Bulk starter media |
-
1983
- 1983-09-06 GB GB08410090A patent/GB2138664A/en not_active Withdrawn
- 1983-09-06 WO PCT/US1983/001342 patent/WO1984001104A1/en not_active Application Discontinuation
- 1983-09-06 DE DE19833390215 patent/DE3390215T1/en not_active Withdrawn
- 1983-09-06 EP EP19830903238 patent/EP0119254A4/en not_active Withdrawn
- 1983-09-06 AU AU20793/83A patent/AU569047B2/en not_active Ceased
- 1983-09-12 IL IL69699A patent/IL69699A0/en unknown
- 1983-09-12 CA CA000436528A patent/CA1202812A/en not_active Expired
- 1983-09-13 NZ NZ205569A patent/NZ205569A/en unknown
- 1983-09-13 ES ES525573A patent/ES525573A0/en active Granted
- 1983-09-14 IT IT22875/83A patent/IT1170217B/en active
-
1984
- 1984-05-14 DK DK238584A patent/DK238584A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IT1170217B (en) | 1987-06-03 |
AU569047B2 (en) | 1988-01-21 |
DE3390215T1 (en) | 1985-01-24 |
EP0119254A1 (en) | 1984-09-26 |
IL69699A0 (en) | 1983-12-30 |
CA1202812A (en) | 1986-04-08 |
DK238584D0 (en) | 1984-05-14 |
DK238584A (en) | 1984-05-14 |
WO1984001104A1 (en) | 1984-03-29 |
ES8503480A1 (en) | 1985-03-01 |
GB2138664A (en) | 1984-10-31 |
IT8322875A0 (en) | 1983-09-14 |
EP0119254A4 (en) | 1986-09-15 |
AU2079383A (en) | 1984-04-04 |
GB8410090D0 (en) | 1984-05-31 |
ES525573A0 (en) | 1985-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4517295A (en) | Hyaluronic acid from bacterial culture | |
Roy et al. | Batch fermentation of whey ultrafiltrate by Lactobacillus helveticus for lactic acid production | |
DK2653533T3 (en) | Lactobacillus with a multi-coating layer and a process for its preparation | |
DE69535290T2 (en) | PREPARATION OF STREPTOCOCCUS THERMOPHILUS FERMENTED HIGH-GRAVITY PRODUCTS OF GALACTO OLIGOSACCHARIDES AND BETA-GALACTOSIDASE | |
DE3688163T2 (en) | Process for the recovery of extracellular enzymes from entire fermentation broths. | |
US4427580A (en) | Method for separation and recovery of proteins and nucleic acids from nucleoproteins using water destructuring salts | |
JPWO2009008362A1 (en) | Method for producing sialic acid compound-containing composition | |
US4544637A (en) | Culture media from clarified diary whey lactose permeates | |
CN115322912B (en) | High-yield strain of ergothioneine, screening method and application thereof | |
AU607199B2 (en) | Plant gum material and use thereof in food products | |
EP0121185A2 (en) | Method for the separation of extracellular amylase and protease produced during the fermentation of enzyme producing microorganisms | |
EP3208332B1 (en) | Lactase solution and milk using same | |
EP3251515A1 (en) | Process for making dairy products free of lactose | |
NZ205569A (en) | Production of clouding agent, stabilising agent, emulsifying agent, thickening agent or microbiological culture medium from dairy whey lactose permeate | |
Corre et al. | Production of concentrated Bifidobacterium bifidum | |
EP3158871B1 (en) | Process for making lactose free dairy products | |
EP3123869B1 (en) | Process for making dairy products free of lactose | |
CA2123262C (en) | Xanthan gum from dairy permeates and other filtered dairy products | |
US4851235A (en) | Production of fermented whey products containing an emulsifier | |
JPS59501933A (en) | Conversion of clarified dairy whey lactose permeate into media and other commercially useful products | |
DE2346335A1 (en) | MICROBIAL MANUFACTURED LIPASES AND THE PROCESS FOR THEIR MANUFACTURING | |
WO2014001103A1 (en) | Method for producing a protein preparation comprising a high vitamin b content | |
DE69000631T2 (en) | PART HYDROLYSATE FROM Whey Proteins, Free Of Lactoglobulin And Enzymatic Process For Obtaining It. | |
JP2933510B2 (en) | Emulsion stabilizer and method for producing food using the same | |
Sushma et al. | Isolation, production and purification of lipase from Aspergillus niger using gingerly oil cake as substrate |